Skip to main content
. 2017 Dec 12;9(3):3946–3955. doi: 10.18632/oncotarget.23280

Figure 2.

Figure 2

Kaplan-Meier plots for (A) the French training cohort stratified by the 24-gene signature; (B) the French validation cohort stratified by the 24-gene hypoxia signature; (C) the TCGA cohort stratified by the 24-gene hypoxia signature; (D) the combined French cohort stratified by both hypoxia signature and CINSARC signature.